Effects of (-)-menthol on arylamine N-acetyltransferase activity in human liver tumor cells

Am J Chin Med. 2001;29(2):321-9. doi: 10.1142/S0192415X01000344.

Abstract

To evaluate whether or not (-)-menthol affects arylamine N-acetyltransferase (NAT) activity, we selected human liver tumor cell line (J 5) for examination. By using high performance liquid chromatography, NAT activity for acetylation of 2-aminofluorene (AF) was determined. (-)-Menthol displayed a dose-dependent inhibition to cytosolic NAT activity. Time-course experiments showed that NAT activity measured from intact human liver tumor cells was inhibited by (-)-menthol for up to 24 hrs. But in human liver tumor intact cells, the low doses (0.0032 and 0.032 mM) of (-)-menthol promoted the NAT activity and the high doses (3.2 and 32 mM) of (-)-menthol inhibited NAT activity and the 0.32 mM (-)-menthol did not show any significant differences between control and (-)-menthol treated groups. Using standard steady-state kinetic analysis, it was demonstrated that (-)-menthol was a possible uncompetitive inhibitor (decrease Km and Vmax) to NAT activity in cytosols. This report is the first demonstration which showed (-)-menthol affect on human liver tumor cells NAT activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Arylamine N-Acetyltransferase / metabolism*
  • Cytosol / enzymology
  • Dose-Response Relationship, Drug
  • Humans
  • Kinetics
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / enzymology*
  • Menthol / pharmacology*
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Menthol
  • Arylamine N-Acetyltransferase